Every two years, the Index methodology is refined based on a targeted review of how stakeholders view pharma’s role in access to medicine. Find out more about the review process and how experts get involved.
Every two years, the Index methodology is refined based on a targeted review of how stakeholders view pharma’s role in access to medicine. Find out more about the review process and how experts get involved.